Search research articles
Contact Us
Filters
Showing results (241-250 of 420) with videos related to
Page
of 42
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 29, 2025
Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)
Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease
|
July 19, 2021
Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019
David B Huang, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
April 8, 2009
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
Céline Vidaillac, Steve N Leonard, Helio S Sader, et al.
Jac-Antimicrobial Resistance
|
October 5, 2022
Prevalence of carbapenemase genes among carbapenem-nonsusceptible <i>Enterobacterales</i> collected in US hospitals in a five-year period and activity of ceftazidime/avibactam and comparator agents
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
November 20, 2013
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups
Mariana Castanheira, Sarah E Farrell, Kevin M Krause, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2014
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
Helio S Sader, David J Farrell, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy
|
June 16, 2025
Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023)
Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.
Journal of Clinical Microbiology
|
February 24, 2026
Inference of ceftobiprole susceptibility through surrogate testing of ceftaroline
Helio S Sader, Rodrigo E Mendes, David P Nicolau, et al.
Surgical Infections
|
April 23, 2016
Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 24, 2004
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
Lalitagauri Deshpande, Paul R Rhomberg, Thomas R Fritsche, et al.
Page
of 42
Search research articles
Search
Showing results (241-250 of 420) with videos related to
Sort By:
Page
of 42
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 29, 2025
Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)
Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease
|
July 19, 2021
Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019
David B Huang, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
April 8, 2009
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
Céline Vidaillac, Steve N Leonard, Helio S Sader, et al.
Jac-Antimicrobial Resistance
|
October 5, 2022
Prevalence of carbapenemase genes among carbapenem-nonsusceptible <i>Enterobacterales</i> collected in US hospitals in a five-year period and activity of ceftazidime/avibactam and comparator agents
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
November 20, 2013
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups
Mariana Castanheira, Sarah E Farrell, Kevin M Krause, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2014
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
Helio S Sader, David J Farrell, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy
|
June 16, 2025
Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023)
Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.
Journal of Clinical Microbiology
|
February 24, 2026
Inference of ceftobiprole susceptibility through surrogate testing of ceftaroline
Helio S Sader, Rodrigo E Mendes, David P Nicolau, et al.
Surgical Infections
|
April 23, 2016
Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 24, 2004
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
Lalitagauri Deshpande, Paul R Rhomberg, Thomas R Fritsche, et al.
Page
of 42